Companies / Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

Nasdaq: NRIXCIK 1549595BRISBANE, CAnurixtx.com

Financials · FY2025

Revenue$83.98M
Net income$-264.46M
Total debt
Cash$67.69M
Diluted EPS$-3.05
Shares outstanding103.8M

Ownership

103.8M shares outstanding · as of Jun 30, 2026
0.19%Insiders
Ownership
Insiders0.19%195,033
Institutions108.73%112,840,998
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Hansen GwennChief Scientific Officer
0.11%115,005
van Houte HansChief Financial Officer
0.04%45,427
Ring ChristineChief Legal Officer
0.03%34,601
Sands Arthur TCEOPresident, CEO · Director

Institutional holders 190

View all →
HolderValue% of shares
BlackRock, Inc.$212.77M8.45%
Redmile Group, LLC$153.54M7.80%
Deep Track Capital, LP$133.48M6.78%
State Street Corporation$113.47M4.51%
Vanguard Group Inc$112.86M5.73%
Morgan Stanley$92.59M4.70%
Vestal Point Capital, LP$88.97M4.52%
Fmr LLC$80.32M4.08%
Baker Bros. Advisors LP$72.21M4.49%
Pictet Asset Management Holding SA$65.78M3.34%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
Deutsche Bank AG
13F manager
Trim$-56.66M-2.3M
-93.91%
151,453
0.15% of shares
high
Q2 2026
as of
State Street Corporation
13F manager
Add$27.12M+1.1M
+31.40%
4,677,244
4.51% of shares
medium
Q1 2026
as of
General Atlantic, L.P.
13F manager
Trim$-12.33M-795K
-16.24%
4,101,865
3.95% of shares
medium
Q1 2026
as of
Millennium Management LLC
13F manager
Add$5.68M+367K
+203.91%
546,297
0.53% of shares
medium
Q1 2026
as of
D. E. Shaw & Co., Inc.
13F manager
New$5.34M+344K
344,203
0.33% of shares
medium
Q4 2025
as of
Bank of America Corp /De
13F manager
Add$4.85M+256K
+53.11%
736,558
0.71% of shares
low
Q2 2025
as of
Boxer Capital Management, LLC
13F manager
Trim$-4.42M-388K
-68.92%
175,000
0.17% of shares
low
Q1 2026
as of
HighVista Strategies LLC
13F manager
New$3.51M+227K
226,546
0.22% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Baker Bros. Advisors LPPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
NRIX67080M103